• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Manufacturing
    • Packaging
    • Development
    • Compliance
    • Top 20
    • Directory
    • Microsites
    • Events
    • More
  • Magazine
  • News
  • Manufacturing
  • Packaging
  • Development
  • Compliance
  • Top 20
  • Directory
  • Microsites
  • Events
  • Current / Back Issue
    Features
    Editorial
    Columns
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Subscribe Now
    Advertise Now
    Top Features
    Cold Chain Packaging and Logistics

    How Artificial Intelligence and Machine Learning are Transforming the Life Sciences

    Challenges of Preparing Highly Potent Oral Products

    Bioprocessing Trends

    Sustainable Manufacturing
    Breaking News
    Online Exclusives
    Industry News
    Collaborations & Alliances
    Promotions & Moves
    Trials & Filings
    Financial Reports
    Bio News & Views
    Custom Sourcing News
    Packaging & Tracking
    CRO News
    Live From Shows
    Top News
    Pasithea Signs CMC Development and Manufacturing Agreement

    Experic Expands Analytical Capabilities and Facilities

    List Labs Expands Manufacturing Capacity

    groninger Continues Growth in the US

    Catalent Bolsters Cell and Gene Services
    APIs
    Aseptic Processing
    Cleaning Validation
    Clinical Trial Materials
    Cytotoxics and High Potency Manufacturing
    Equipment
    Excipients
    Extractables and Leachables
    Facilities
    Fill/Finish
    Lyophilization
    Parenterals
    Process Development
    Process Validation
    Risk Management
    Scale-up/ Technology Transfer
    Solid Dosage/ Creams/ Ointments

    What Does the Future of API Synthesis Look Like?

    Pasithea Signs CMC Development and Manufacturing Agreement

    Experic Expands Analytical Capabilities and Facilities

    List Labs Expands Manufacturing Capacity

    Jaguar Health Achieves Key Milestone for Crofelemer API Manufacturer
    Capsules
    Cold Chain Management
    Injectables
    Logistics
    Serialization
    Solid Dosage / Semi-solids
    Supply Chain
    Vials

    Catalent Bolsters Cell and Gene Services

    CDMO Sirio Pharma Completes the Acquisition of Best Formulations

    Meeting the Container Closure Integrity Requirements in the Revised EU Annex 1

    Case Study: Secondary Sourcing Strategies to Ensure Supply Chain Security

    Beat the Supply Chain Backlog
    Analytical Services
    Bioanalytical Services
    Bioassay Developement
    Biologics, Proteins, Vaccines
    Biosimilars
    Chemistry
    Clinical Trials
    Drug Delivery
    Drug Development
    Drug Discovery
    Formulation Development
    Information Technology
    Laboratory Testing
    Methods Development
    Microbiology
    Preclinical Outsourcing
    R&D
    Toxicology

    Experic Expands Analytical Capabilities and Facilities

    List Labs Expands Manufacturing Capacity

    Catalent Bolsters Cell and Gene Services

    Crown Bioscience to Acquire Indivumed’s Service Biz and Supporting Biobank

    Stevanato Group, Transcoject Partner on Pre-Fillable Syringe Polymer Options
    Filtration & Purification
    GMPs/GCPs
    Inspections
    QA/QC
    Regulatory Affairs
    Validation

    Adare Partners with Veeva to Strengthen Quality Operations

    KBI Secures Swissmedic Regulatory Establishment License for Facility in Geneva

    Enhancing Ease of Use, Batch Turnaround, and Process Flexibility

    Understanding the Essential Role of a Qualified Person

    Altasciences Los Angeles Clinical Site Receives CAP Accreditation
    Companies
    Categories
    Corporate Capabilities
    Add New Company
    Contract Service Directory Companies
    Quotient Sciences

    LOTTE BIOLOGICS

    Syngene International Ltd.

    Chiron Recombinant Proteins

    Alcami
    Companies
    News Releases
    Posters
    Brochures
    Services
    Videos
    Case Study
    White Papers
    Jobs
    Contract Service Directory Companies
    Quotient Sciences

    LOTTE BIOLOGICS

    Syngene International Ltd.

    Chiron Recombinant Proteins

    Alcami
    Webinars
    Live From Shows
    • Magazine
      • Current / Back Issue
      • Features
      • Editorial
      • Columns
      • Editorial Guidelines
      • Subscribe Now
      • Advertise Now
      • Enewsletter Archive
      • Digital Edition
    • Directory
      • Companies
      • Categories
      • Corporate Capabilities
      • Add Your Company
    • Manufacturing
      • APIs
      • Aseptic Processing
      • Cleaning Validation
      • Clinical Trial Materials
      • Cytotoxics and High Potency Manufacturing
      • Equipment
      • Excipients
      • Extractables and Leachables
      • Facilities
      • Fill/Finish
      • Lyophilization
      • Parenterals
      • Process Development
      • Process Validation
      • Risk Management
      • Scale-up/ Technology Transfer
      • Solid Dosage/ Creams/ Ointments
      • cGMP Manufacture
    • Packaging
      • Capsules
      • Cold Chain Management
      • Injectables
      • Logistics
      • Serialization
      • Solid Dosage / Semi-solids
      • Supply Chain
      • Vials
    • Development
      • Analytical Services
      • Bioanalytical Services
      • Bioassay Developement
      • Biologics, Proteins, Vaccines
      • Biosimilars
      • Chemistry
      • Clinical Trials
      • Drug Delivery
      • Drug Development
      • Drug Discovery
      • Formulation Development
      • Information Technology
      • Laboratory Testing
      • Methods Development
      • Microbiology
      • Preclinical Outsourcing
      • R&D
      • Toxicology
    • Compliance
      • Filtration & Purification
      • GMPs/GCPs
      • Inspections
      • QA/QC
      • Regulatory Affairs
      • Validation
    • Top 25 Pharma & BioPharma
    • Contract Pharma Direct
    • Breaking News
    • Online Exclusives
    • Slideshows
    • Experts Opinions
    • Surveys
      • Outsourcing Survey
      • Salary Survey
    • Glossary
    • Videos
    • White Papers
    • Podcasts
    • Infographics
    • Microsites
      • Companies
      • News Releases
      • Posters
      • Brochures
      • Services
      • Videos
      • Case Study
      • White Papers
    • Contract Pharma Conference
      • Contract Pharma Conference
      • Speakers
      • Exhibitors
      • Conference Sessions
    • eBook
    • Webinars
    • Events
      • Industry Events
      • Live from Show Events
      • Webinars
    • Classifieds / Job Bank
      • Classifieds
      • Job Bank
    • About Us
      • About Us
      • Contact Us
      • Advertise With Us
      • Privacy Policy
      • Terms of Use
    Columns

    Sterile Drug Manufacturing

    Does it really exist, or is it just a theoretical concept?

    Sterile Drug Manufacturing
    Related CONTENT
    • Contracting And Outsourcing Exhibitor List
    • Vetio Animal Health
    • CDMO-Sponsor Partnerships & Outsourcing
    • 2017 Contracting & Outsourcing Conference Wrap up
    • The Orwellian Future of Pharmacogenomics
    Ben Locwin, Contributing Editor10.11.17
    Batch success rates have been generally in the mid-90 percentile for a decade, and as with many things you put an economic lens to, the marginal cost of inching ever-upward towards 100% success rate becomes very expensive. In fact, as with safety incidents across organizations, success rate in batch production is something that can never be 100% anyway. There will always be failure modes that with some probability will occur. Certain companies, and within certain boundarized time intervals, could indeed try to lay claim to “100% batch success rate,” but when we see that published in an advertisement in the future, we’ll all know better and can quietly chuckle to ourselves.

    Even still, we keep innovating. There have been incredible gains within our industry in terms of design and development of disposable/single-use technologies—to the extent that our past-selves from 10 or 15 years ago would have thought that our current state today of integration of single-use consumables would have been unlikely. Clearly, many so-called ‘sterility’ issues arise due to external penetration of the process for additions of supplements as well as process sampling, and better use of process analytical technologies (PAT) and further momentum towards continuous manufacturing reduces the probabilities of contamination by decrementing the overall number of bioreactor infiltrations. But in order to help us face hard realities and better appraise our marginal costs as we continue into the future of this topic, read the following header:

    It’s never sterile
    As an industry, we haven’t done ourselves any favors by subverting science and putting resources in patently falsifiable goals, and one of these is pursuit-at-all-costs of “sterile” manufacturing. Sterility is a theoretical construct that doesn’t exist in practice. Sterility is a probabilistic unicorn, and like reducing workplace safety incidents to “zero”—so long as humans are employed in the processes—is an impossible goal. Such is the world of risk assessments, where we can reduce the theoretical occurrence of an outcome, such as an infiltrating microbe, to very, very low numbers approaching zero—as with safety defects—but they won’t be zero for more than small snapshots of time or progressively-small spatial integrals within a bioprocess. For example, if you swab a surface to test for microbes, there calls into question the initial ‘sterility’ of the swab instrument, the accuracy of the lab testing to identify a single microorganism, or its residues, and the surface area ‘slice’ of the vessel or piping that you exposed to testing because it surely wasn’t all of the process-contact surface area. Results are then extrapolated to potentially suggest that sterility exists.

    I’ve been in silicon wafer microprocessor cleanrooms—entire vertical laminar flow rooms, not just BSCs—as well as cleanrooms in biopharma and BSL-2, 3, and 4 facilities. Sterility exists in none of them. But most cases of single-organism presence will not lead to an abject contamination because very small numbers of microbes in isolated cases can have very difficult times persisting, even in mesophilic environments.

    The null hypothesis
    Are CIPd/SIPd hard piping sections sterile? No. There we use F0 calculus to give us a probability that there would be organisms existing after a particular sterilization cycle. How about single-use disposables that are gamma-irradiated? It’s great technology, both on the side of the durable good, as well as on the side of the radiation physics. But it’s still not a guarantee of sterility. In fact, radioactive half-lives themselves are based on underlying probabilities discovered by George Gamow, and it’s not possible to say with certainty in a radioactively-decaying sample of an element whether “this” atom will decay to its isotope or if “this other one” will instead.

    We never test every infinitesimally-small section of each system over long enough timelines to empirically say that they’re “sterile.” But what we can (and do) do a good job of is having systems which we can maintain as aseptic. That is, endeavoring to make them free from foreign organisms, or what my medical dictionary lists as “restricting microorganisms in the environment and preventing contamination of the surgical wound.” Philosophically and semantically, this difference between “sterile” and “aseptic” is like the difference between the proper phrasing of null hypothesis significance testing. If you were to perform a statistical test on two groups to test if they are different from each other, the null hypothesis isn’t that the two groups “are the same,” it’s that the two groups “are not different.” And this is a big difference.

    But what we don’t have in pharma manufacturing is an epidemic of sterility problems leading to patient illness or damage. In fact, during a review of end-user (patient) complications due to improper practices or lack of asepticity, issues at the pharma manufacturing level are ultra-rare. The British Medical Journal published in 2013 a treatise (Makary, author) on how ‘medical error’ is the third leading cause of death in the U.S. These are patient-facing practices that are directly causing or leading attributably to death. Upon statistical evaluation of the impact that defects in drug production, including aseptic issues, have on patients via a rare events statistical process control chart, there isn’t even a detectable signal. Not so in actual patient care centers.

    The state of affairs at the patient-treatment level
    I’ve spent a lot of time at cancer centers recently reviewing their protocols and practices. One thing I can tell you is that I have more than 42 pages documenting improper aseptic procedures undertaken by care staff, cleaners, facility design, and visitor requirements. And to further add gravity to this measure, each page has more than 12 observations with notes for each. Why does this matter? Well, principally, those inpatients at cancer centers are among the most susceptible of healthcare populations because they are significantly immunocompromised while undergoing chemotherapy, radiation treatment, experimental CAR-T, and any other modality. If we look at the patient-centric goal of these treatments, they’re to make people better. But in many cases, the practices extrinsic to the actual invasive treatments themselves produce more risk than they prevent. 8 ½ x 11” pieces of paper printed with an admonishment to “make sure you clean your hands… Clean hands prevent infections” hanging on hallway bulletin boards and elevator walls doesn’t do anything to encourage staff to better adhere to aseptic practices, and it gives visitors a point to pause and reflect on: “You mean to tell me that trained medical staff need to be assaulted by homemade signs in a multi-million-dollar cancer center because they don’t do it properly?” And I can also tell you that there was no visible protocol or procedure, no trainer available, and no oversight of visitors when they were told in critical care areas to don nitrile gloves and facemasks, including one instance observed of a visitor putting the surgical mask on backwards.

    We do the best we can in industry given all the moving parts we are working with. We capture deviations to investigate as an industry where things are going awry, and we help each other by cross-pollination of ideas, vendors, and technologies, to continue the drive to make things better. But we should still probably call it ‘aseptic manufacturing,’ because that’s more accurate. And frankly, it’s more catchy than “aspirationally-sterile manufacturing.”


    Ben Locwin

    Ben Locwin, PhD, MBA, MS writes the Clinically Speaking column for Contract Pharma and is an author of a wide variety of scientific articles for books and magazines, as well as an acclaimed speaker. He is an expert media contact for the American Association of Pharmaceutical Scientists (AAPS) and a committee member for the American Statistical Association (ASA). He also provides advisement to many organizations and boards for a range of business, healthcare, clinical, and patient concerns. He can be reached at ben.locwin@healthcarescienceadvisors.com
    Related Searches
    • sterile manufacturing
    • pat
    • production
    • Pharma
    Suggested For You
    Contracting And Outsourcing Exhibitor List Contracting And Outsourcing Exhibitor List
    Vetio Animal Health Vetio Animal Health
    CDMO-Sponsor Partnerships & Outsourcing CDMO-Sponsor Partnerships & Outsourcing
    2017 Contracting & Outsourcing Conference Wrap up 2017 Contracting & Outsourcing Conference Wrap up
    The Orwellian Future of Pharmacogenomics The Orwellian Future of Pharmacogenomics
    DSCSA Deadline Approaches DSCSA Deadline Approaches
    5 Tips to Make the Most of Contract Pharma 5 Tips to Make the Most of Contract Pharma's Conference & Tabletop Exhibition
    Ready for BIO 2017? Ready for BIO 2017?
    Heading to BIO 2017! Heading to BIO 2017!
    Newsmakers: Lee Karras Newsmakers: Lee Karras
    So You Think You Know  All About Excipients? So You Think You Know All About Excipients?
    CROs & Next-Gen  Drug Development CROs & Next-Gen Drug Development
    Biomanufacturing Trends and Outlook 2017: Where Is It All Going? Biomanufacturing Trends and Outlook 2017: Where Is It All Going?
    Injectable Drug Delivery Trends Injectable Drug Delivery Trends

    Related Live From Shows

    • Contracting And Outsourcing Exhibitor List

      ...
      09.06.22

    • Vetio Animal Health

      Vetio Animal Health

      ...
      John Kane, CEO 10.24.19

    • APIs
      CDMO-Sponsor Partnerships & Outsourcing

      CDMO-Sponsor Partnerships & Outsourcing

      A conversation with Kevin Cook, the chief executive at Sterling Pharma Solutions.
      10.10.17


    • 2017 Contracting & Outsourcing Conference Wrap up

      2017 Contracting & Outsourcing Conference Wrap up

      Another year of record attendance, sold-out exhibit hall, and sessions addressing key industry topics
      10.06.17

    • R&D
      The Orwellian Future of Pharmacogenomics

      The Orwellian Future of Pharmacogenomics

      Coming soon to people near you
      Ben Locwin 09.06.17

    Loading, Please Wait..
    Trending
    • Sarepta And Catalent Expand Manufacturing Partnership
    • Forge Biologics Strengthens Genetic Medicine CDMO Capabilities
    • Colorcon Signs Agreement To Purchase Airnov Healthcare Packaging
    • The Ongoing Evolution And Implementation Of DCTs In 2023
    • EyePoint Pharmaceuticals To Build GMP Mfg. Facility In Northbridge, MA
    Breaking News
    • Pasithea Signs CMC Development and Manufacturing Agreement
    • Experic Expands Analytical Capabilities and Facilities
    • List Labs Expands Manufacturing Capacity
    • groninger Continues Growth in the US
    • Catalent Bolsters Cell and Gene Services
    View Breaking News >
    CURRENT ISSUE

    November/December 2022

    • Cold Chain Packaging and Logistics
    • Optimizing Supply Chains for Allogeneic Cell Therapy Trials
    • Sustainable Manufacturing
    • Bioprocessing Trends
    • How Artificial Intelligence and Machine Learning are Transforming the Life Sciences
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    Probiotics Supplementation Reduces Complications in Colorectal Cancer Patients
    Vitamin D Supplementation Reduces Risk of Dynapenia
    Sustained-Release Caffeine Ingredient Offers Mood, Performance Benefits
    Coatings World

    Latest Breaking News From Coatings World

    Epoxytec Announces New Website Launch
    Paints and Coatings Market Worth $212B by 2026: MarketsandMarkets
    Axalta Releases Fourth Quarter and Full Year 2022 Results
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    BMP Medical Expands Sterling, Massachusetts Facility
    Abbott's Proclaim XR SCS OK'ed for Diabetic Neuropathy
    Environmental Sustainability Becoming Increasingly Important to Medtech Industry
    Contract Pharma

    Latest Breaking News From Contract Pharma

    Pasithea Signs CMC Development and Manufacturing Agreement
    Experic Expands Analytical Capabilities and Facilities
    List Labs Expands Manufacturing Capacity
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    Haircare Brand Uncle Funky’s Daughter Announces Retail Expansion
    TRESemmé Introduces New Pro Infusion Collection
    Walgreens Boots Alliance Shares 2022 ESG Report
    Happi

    Latest Breaking News From Happi

    KimChi Beauty Launches Spinning Hearts Love 02 Ahead of Valentine’s Day
    Dark & Lovely Names Actress Meagan Good Brand Ambassador
    Natural Household Care Company Tru Earth Adds Dishwasher Detergent Tablets
    Ink World

    Latest Breaking News From Ink World

    Xerox Releases 4Q, Full-Year 2022 Results
    Electronics For Imaging Names Frank Pennisi as CEO
    Fiery to Separate from EFI, Remain Wholly-Owned by Siris
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    EFI appoints Frank Pennisi CEO, Fiery now an independent business
    Bobst boosts senior sales team with Keith Nagle
    Penmar Industries adds Screen Truepress Jet L350UV SAI digital press
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    Essity’s Sales Grow
    Thinx to Pay up to $5 million to Settle Class Action Suit
    Typar Highlighting New Building Innovations
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    Orthofix Launches the Mariner Deformity System
    Tyber Medical Hires 2 New Execs
    Miach Ortho Raises $40M in Series B Funding
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    Smart Devices with Privacy Focus Have More Consumer Appeal
    Siman Group Partners with SML to Unlock Full Retail Potential with RFID
    Brewer Science Presents Optics Integration Solutions at SPIE Photonics West

    Copyright © 2023 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login